Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies.
The Boehringer Ingelheim group of companies' objectives and beliefs can be summed up in a single phrase: Value through Innovation, the central concept of our corporate vision.
Research & Development
Our new discovery research strategy aims at enhancing our capacity for innovation and at encouraging scientific creativity for diseases with high unmet medical need.
How We Discover
From initial discovery to a marketable medicine is a long, challenging road. It takes about 12 - 15 years from discovery to the approved medication and requires an investment of about US $1 billion.
Working at Boehringer Ingelheim – Being part of a global family
As a research-driven pharmaceutical company Boehringer Ingelheim strives to improve health of people and animals everywhere in the world.
Boehringer Ingelheim takes responsibility for nature and the climate. Read more and find out how this generates greater efficiency and innovative products.
Making More Health
MMH Talk of Francesca Fidelli
@BOEHRINGER 14 Jun 2016 at 13:28
In case you missed our #ChatAsthma tweetchat yesterday w/ @russell_doc here's a wrap up: http://bit.ly/ChatAsthma2016 #EAACI2016 #hcsmeu #asthma
25 May 2016 at 09:00
Boehringer Ingelheim increases access to the medication for the treatment of HIV/Aids
11 May 2016 at 09:00
Nine out of 10 AF patients are concerned about stroke and many want to be part of OAC treatment decisions, new international survey shows
Ask questions, get answers, receive tips, welcome to the Boehringer Ingelheim career blog